Skip to main content
Equibles
DNTH logo

DNTH · Dianthus Therapeutics, Inc. /DE/ · Holdings

Track DNTH — free

Use DNTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DNTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$78.75 +4.21 (+5.65%)
Russell 2000 member Rebalance outlook locked
Going-concern doubt — cleared Aug 4, 2026

The latest filing states the doubt was alleviated.

“In accordance with Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying unaudited condensed consolidated financial statements were issued (the "issuance date") As of the issuance date, the Company expects that its existing cash, cash equivalents and investments on hand will be sufficient to fund its obligations as they become due for at least twelve months beyond the issuance date.”
View the 10-Q filed Aug 4, 2026
Market Cap
$4.17B
Shares
55.93M
Volume · Oct 20 1.87M Avg daily vol (3M) 822.38K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of DNTH: 13F, 13D and 13G, insiders and funds →
Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 274
Total Value: $6,494,514,139
Total Shares: 66,695,438
Showing 1–100 of 280 holdings by value · page 1 of 3

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 272 13F filers
Top Holder
12.4%
Sep 2023 → Jun 2026 · range 11.6% – 22.0%
of institutional value
Top 5
33.2%
Sep 2023 → Jun 2026 · range 29.8% – 77.1%
of institutional value
Top 10
49.8%
Sep 2023 → Jun 2026 · range 44.8% – 95.5%
of institutional value
HHI
370
Sep 2023 → Jun 2026 · range 332 – 1,378
Broadly held

Who Holds DNTH

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 269 filers, like-for-like change +5.7%; actively managed books +2.0%; index-like books +25.6%.

Holder type Share Filers Change
Registered adviser 49.6% 134 -7.4%
Exempt adviser 0.9% 5 +6.1%
Adviser 9.1% 11 +63.9%
Bank 7.7% 17 +50.3%
Insurer 0.0% 2 +22.5%
Broker-dealer 0.1% 2 +38.5%
Benefit plan 0.1% 5 +26.6%
Non-US 0.2% 7 -59.9%
Holding company 24.7% 10 +12.2%
Unknown 7.6% 76 +10.0%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 4 holders with no observed 2026-03-31 13F and 1 holder with no observed 2026-06-30 13F. Compared across CIK changes: JANUS HENDERSON GROUP PLC continues as Jupiter Topco LLC.

Conviction and Crowding

269 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
10
3.72% of filers hold it in their top 10
Mar 31, 2026: 17
Holders above 5%
4
median weight 0.007%
Mar 31, 2026: 6
Crowding
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Top 10 holders
50.1%
of 13F shares, Herfindahl 0.037
Active holders
+2.0%
like-for-like share change of active filers
5% stakes on record
9
0 13D, 9 13G (6 institutional, 3 passive, 0 exempt)
How long holders have held it value-weighted 7.2 quarters
Under 1 year 26.5% 1 to 3 years 44.5% 3 years or more 29.0% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $597,416 (1 buying, 2 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$46.32
estimated per share
Mar 31, 2026: $35.90
Quarter-end price
$97.48
implied by 13F values
Estimated gain or loss
+110.5%
price against the estimated cost
Estimated at a loss
0.000%
of costed 13F value

Estimated cost covers 94.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies DNTH's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 SYRE Spyre Therapeutics, Inc. 26
2 ELVN Enliven Therapeutics, Inc. 25
3 SVRA Savara Inc 18
4 COGT Cogent Biosciences, Inc. 25
5 ERAS Erasca, Inc. 20
6 ORKA Oruka Therapeutics, Inc. 23
7 XENE Xenon Pharmaceuticals Inc. 22
8 TNGX Tango Therapeutics, Inc. 18
9 RVMD Revolution Medicines, Inc. 31
10 TRVI Trevi Therapeutics, Inc. 18

Shareholder Targets

13F filers that own its peers but not DNTH, quarter ended Jun 30, 2026

Found through its holder-overlap peers: SYRE, ELVN, SVRA, COGT, ERAS, ORKA, XENE, TNGX, RVMD, TRVI, PRAX, DFTX, GPCR, MIRM, PHVS, AVTX, DYN, BLTE, TARS, CYTK. 925 filers in all.

# Filer In peers
1 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $2,968,393,034 4 held
2 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $2,474,663,460 7 held
3 Darwin Global Management, Ltd. Exempt adviser, Concentrated $2,464,598,631 2 held
4 Avoro Capital Advisors LLC Registered adviser, Concentrated $1,938,000,613 6 held
5 Frazier Life Sciences Management, L.P. Registered adviser, Concentrated $1,816,558,079 7 held
6 Capital World Investors Adviser, Diversified active $1,753,690,262 8 held
7 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $1,479,480,949 9 held
8 Nextech Invest, Ltd. Exempt adviser, Concentrated $1,423,531,573 1 held
9 Siren, L.L.C. Unknown, Diversified active $1,180,798,016 13 held
10 Deep Track Capital, LP Adviser, Diversified active $1,177,615,011 10 held

Fund Ownership of DNTH by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.23% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.48% 1,389,657
Index ETFs 10.74% 6,008,899
Active ETFs 0.48% 270,894
Active funds 28.68% 16,042,281
Unclassified 0.59% 327,769
All registered funds 42.98% 24,039,500
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Holder type: Registered adviser 139 Exempt adviser 5 Adviser 11 Bank 17 Insurer 2 Broker-dealer 2 Benefit plan 5 Non-US 7 Holding company 10 Unknown 76
Showing 100 of 280
All Common Calls Puts
Export CSV
Holder Value (USD) % of 13F Shares Open
FMR LLC $799,325,568 12.31% 8,199,893
BlackRock, Inc. $401,990,159 6.19% 4,123,822
T. Rowe Price Investment Management, Inc. $379,046,690 5.84% 3,888,456
WELLINGTON MANAGEMENT GROUP LLP $314,848,893 4.85% 3,229,882
Fairmount Funds Management LLC $247,325,378 3.81% 2,537,191
PRICE T ROWE ASSOCIATES INC /MD/ $245,156,935 3.77% 2,514,946
STATE STREET CORP $229,803,251 3.54% 2,357,440
VANGUARD CAPITAL MANAGEMENT LLC $210,514,688 3.24% 2,159,568
Avidity Partners Management LP $205,115,856 3.16% 2,104,184
Octagon Capital Advisors LP $179,525,699 2.76% 1,841,667
TCG Crossover Management, LLC $163,437,307 2.52% 1,676,624
FRED ALGER MANAGEMENT, LLC $126,967,017 1.95% 1,302,493
GEODE CAPITAL MANAGEMENT, LLC $122,678,774 1.89% 1,258,502
Venrock Adviser, LLC $115,026,400 1.77% 1,180,000
UBS Group AG $111,152,543 1.71% 1,140,260
DEERFIELD MANAGEMENT COMPANY, L.P. $109,695,511 1.69% 1,125,313
JENNISON ASSOCIATES LLC $99,601,456 1.53% 1,021,763
Polar Capital Holdings Plc $99,305,410 1.53% 1,018,726
CITADEL ADVISORS LLC $95,034,324 1.46% 974,911
FRANKLIN RESOURCES INC $94,456,462 1.45% 968,983
BAKER BROS. ADVISORS LP $83,068,946 1.28% 852,164
ALLIANCEBERNSTEIN L.P. $81,312,942 1.25% 834,150
Logos Global Management LP $77,984,000 1.20% 800,000
Cormorant Asset Management, LP $73,110,000 1.13% 750,000
Assenagon Asset Management S.A. $64,474,260 0.99% 732,246
BRAIDWELL LP $57,957,903 0.89% 594,562
VANGUARD PORTFOLIO MANAGEMENT LLC $55,574,810 0.86% 570,115
AMERIPRISE FINANCIAL INC $51,859,259 0.80% 531,999
Woodline Partners LP $48,793,419 0.75% 500,548
BARCLAYS PLC $42,087,281 0.65% 431,753
LORD, ABBETT & CO. LLC $41,154,593 0.63% 422,185
MPM BIOIMPACT LLC $40,941,794 0.63% 420,002
NORTHERN TRUST CORP $40,141,385 0.62% 411,791
Affinity Asset Advisors, LLC $38,992,000 0.60% 400,000
SILVERARC CAPITAL MANAGEMENT, LLC $38,017,200 0.59% 390,000
GOLDMAN SACHS GROUP INC $37,253,053 0.57% 382,161
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $35,674,073 0.55% 365,963
Bain Capital Life Sciences Investors, LLC $35,333,575 0.54% 362,470
Spruce Street Capital LP $34,587,463 0.53% 354,816
Vivo Capital, LLC $34,507,725 0.53% 353,998
DIMENSIONAL FUND ADVISORS LP $31,340,110 0.48% 321,503
WESTFIELD CAPITAL MANAGEMENT CO LP $30,697,816 0.47% 314,914
VANGUARD FIDUCIARY TRUST CO $29,485,945 0.45% 302,482
Driehaus Capital Management LLC $28,782,529 0.44% 295,266
First Turn Management, LLC $27,856,957 0.43% 285,771
TANG CAPITAL MANAGEMENT LLC $25,802,176 0.40% 264,692
Artisan Partners Limited Partnership $25,176,062 0.39% 258,269
BANK OF AMERICA CORP /DE/ $25,036,079 0.39% 256,833
Bank of New York Mellon Corp $24,993,183 0.38% 256,393
RTW INVESTMENTS, LP $24,181,181 0.37% 248,063
EMERALD ADVISERS, LLC $24,156,031 0.37% 247,805
Pictet Asset Management Holding SA $24,106,316 0.37% 247,295
TD Asset Management Inc $21,965,558 0.34% 225,334
EVENTIDE ASSET MANAGEMENT, LLC $21,958,442 0.34% 225,261
LMR Partners LLP $21,835,032 0.34% 223,995
Candriam S.C.A. $19,906,780 0.31% 204,214
STEMPOINT CAPITAL LP $19,578,955 0.30% 200,851
Qube Research & Technologies Ltd $19,196,151 0.30% 196,924
SAMLYN CAPITAL, LLC $19,137,856 0.29% 196,326
Nicholas Investment Partners, LP $18,206,242 0.28% 186,769
ADAGE CAPITAL PARTNERS GP, L.L.C. $18,033,800 0.28% 185,000
Ensign Peak Advisors, Inc $16,979,748 0.26% 174,187
TimesSquare Capital Management, LLC $16,216,480 0.25% 166,357
Atika Capital Management LLC $16,084,198 0.25% 165,000
Artia Global Partners LP $15,888,265 0.24% 162,990
Balyasny Asset Management L.P. $15,792,247 0.24% 162,005
NEUBERGER BERMAN GROUP LLC $15,360,313 0.24% 157,574
Alyeska Investment Group, L.P. $14,679,708 0.23% 150,592
Russell Investments Group, Ltd. $13,981,651 0.22% 143,431
Eagle Health Investments LP $12,803,413 0.20% 131,344
EMERALD MUTUAL FUND ADVISERS TRUST $12,771,634 0.20% 131,018
MARSHALL WACE, LLP $12,549,867 0.19% 128,743
PFM Health Sciences, LP $11,816,720 0.18% 121,222
Tri Locum Partners LP $11,767,005 0.18% 120,712
Nuveen, LLC $11,644,960 0.18% 119,460
ORBIMED ADVISORS LLC $11,210,200 0.17% 115,000
Patient Square Capital LP $10,527,840 0.16% 108,000
TWO SIGMA INVESTMENTS, LP $10,474,713 0.16% 107,455
MORGAN STANLEY $10,369,527 0.16% 106,376
Caption Management, LLC $10,128,172 0.16% 103,900
SEVEN GRAND MANAGERS, LLC $9,748,000 0.15% 100,000
FIRST TRUST ADVISORS LP $9,177,936 0.14% 94,152
SUSQUEHANNA INTERNATIONAL GROUP, LLP $9,133,876 0.14% 93,700
SEI INVESTMENTS CO $8,995,453 0.14% 92,280
MILLENNIUM MANAGEMENT LLC $8,952,368 0.14% 91,838
VICTORY CAPITAL MANAGEMENT INC $8,608,946 0.13% 88,315
AMERICAN CENTURY COMPANIES INC $8,564,592 0.13% 87,860
Rhenman & Partners Asset Management AB $8,395,659 0.13% 86,127
Invesco Ltd. $8,344,579 0.13% 85,603
Caption Management, LLC $7,505,960 0.12% 77,000
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $7,349,599 0.11% 75,396
Moody Aldrich Partners LLC $7,267,328 0.11% 74,552
Swiss National Bank $7,194,024 0.11% 73,800
SUSQUEHANNA INTERNATIONAL GROUP, LLP $7,116,040 0.11% 73,000
DEUTSCHE BANK AG\ $6,799,814 0.10% 69,756
MERCER GLOBAL ADVISORS INC /ADV $6,402,778 0.10% 65,683
LPL Financial LLC $6,364,956 0.10% 65,295
Seven Fleet Capital Management LP $6,309,197 0.10% 64,723
SummitTX Capital, L.P. $6,225,657 0.10% 63,866
MANUFACTURERS LIFE INSURANCE COMPANY, THE $6,124,570 0.09% 62,829

Showing the top 100 of 280 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1690585 CUSIP 252828108 13F (30d) 12 filings 12 filers Visit website Investor relations